Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin

• Donglin Zhang, BA,
• Kimberly Sable, MD,
• Allison Miller, MD,
• Molly Hinshaw, MD,
• Timothy Schmidt, MD,
• Bridget E. Shields, MD

Affiliations

Donglin Zhang, BA

Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

Kimberly Sable, MD

Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

Allison Miller, MD

Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

Molly Hinshaw, MD

Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

Timothy Schmidt, MD

Department of Hematology and Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

Bridget E. Shields, MD

Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; Correspondence to: Bridget E. Shields, MD, Department of Dermatology, University of Wisconsin School of Medicine and Public Health, 1 S Park St, 7th Floor, Madison, WI 53715.